Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden

Abstract Background Lung cancer is the leading cause of cancer death worldwide. With the growing number of targeted therapies and the introduction of immuno-oncology (IO), personalized medicine has become standard of care in patients with metastatic disease. The development of predictive and prognos...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Guus R. M. van den Heuvel, Leonie I. Kroeze, Marjolijn J. L. Ligtenberg, Katrien Grünberg, Erik A. M. Jansen, Daniel von Rhein, Richarda M. de Voer, Michel M. van den Heuvel
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Accès en ligne:https://doaj.org/article/ae1a0ade6c6e4ed78175927614767cf1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!